Atria Investments’s Rentokil RTO Stock Holding History

Atria Investments’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$797K	Buy	27,858 +904	+3%	+$28.7K	0.01%	1236
2026 Q1	$849K	Buy	26,954 +17,106	+174%	+$539K	0.01%	1151
2025 Q4	$290K	Buy	+9,848	New	+$274K	﹤0.01%	1756
2025 Q3	–	Sell	-8,895	Closed	-$213K	–	2131
2025 Q2	$213K	Sell	8,895 -1,973	-18%	-$45.7K	﹤0.01%	1889
2025 Q1	$249K	Sell	10,868 -2,461	-18%	-$59.4K	﹤0.01%	1721
2024 Q4	$337K	Sell	13,329 -2,381	-15%	-$60.3K	﹤0.01%	1537
2024 Q3	$392K	Sell	15,710 -2,097	-12%	-$62.1K	﹤0.01%	1457
2024 Q2	$528K	Buy	+17,807	New	+$494K	0.01%	1270

Other funds holding RTO

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Atria Investments's RTO Position: Q2 2026 in Review

Atria Investments increased its Rentokil (RTO) stake by 3.4% in Q2 2026, buying an estimated $28.7K and bringing the position to 27,858 shares worth $797K. The position accounts for 0.01% of the portfolio, ranked #1236.

Atria Investments first reported a position in RTO in Q2 2024 and has held it in 8 quarters since. The position peaked at $849K in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

Atria Investments held 27,858 shares of Rentokil worth $797K as of Q2 2026.
Atria Investments bought 904 Rentokil shares in Q2 2026, an estimated $28.7K.
Rentokil made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1236 holding.
Atria Investments first reported a position in Rentokil in Q2 2024 and has held it in 8 quarters since.
Atria Investments's Rentokil position peaked at $849K in Q1 2026.
284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.